27 related articles for article (PubMed ID: 33978213)
21. Glutathione transferases and development of new principles to overcome drug resistance.
Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM
Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652
[TBL] [Abstract][Full Text] [Related]
22. Glutathione-related enzymes, glutathione and multidrug resistance.
Moscow JA; Dixon KH
Cytotechnology; 1993; 12(1-3):155-70. PubMed ID: 7765324
[TBL] [Abstract][Full Text] [Related]
23. Chemoresistance in Malignant Intracranial Tumors: Longer Survival with Negative MDR1 Expression.
Ezgu MC; Kural C; Simsek GG; Kaygin P; Oguztuzun S; Kirik A; Yasar S; Kose G; Sarialtin SY; Coban T; Kul O
Turk Neurosurg; 2021; 31(3):447-459. PubMed ID: 33978213
[TBL] [Abstract][Full Text] [Related]
24. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance in brain tumors: roles of the blood-brain barrier.
Régina A; Demeule M; Laplante A; Jodoin J; Dagenais C; Berthelet F; Moghrabi A; Béliveau R
Cancer Metastasis Rev; 2001; 20(1-2):13-25. PubMed ID: 11831641
[TBL] [Abstract][Full Text] [Related]
26. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.
Wacher VJ; Wu CY; Benet LZ
Mol Carcinog; 1995 Jul; 13(3):129-34. PubMed ID: 7619215
[No Abstract] [Full Text] [Related]
27. Regulation of multidrug resistance by pro-inflammatory cytokines.
Ho EA; Piquette-Miller M
Curr Cancer Drug Targets; 2006 Jun; 6(4):295-311. PubMed ID: 16848721
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
